JEFFREY M NEWLAND

Eye and Vision Services Providers|Optometrist DES MOINES, IA NPI 1326619982

General Payments — all program years on this page

$2,006.52

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 53
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $959.77 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $959.7721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $53.313
2022 $327.299
2023 $666.1520
2024 $959.7721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105113698 ABBVIE INC. $34.06 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105113700 ABBVIE INC. $30.09 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139120116 Tarsus Pharmaceuticals, Inc. $7.33 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139120118 Tarsus Pharmaceuticals, Inc. $34.96 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139120120 Tarsus Pharmaceuticals, Inc. $30.18 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139120122 Tarsus Pharmaceuticals, Inc. $121.13 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139120124 Tarsus Pharmaceuticals, Inc. $34.35 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364163 Bausch & Lomb Americas Inc. $124.98 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364165 Bausch & Lomb Americas Inc. $23.57 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364167 Bausch & Lomb Americas Inc. $22.93 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364169 Bausch & Lomb Americas Inc. $8.51 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364171 Bausch & Lomb Americas Inc. $8.20 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364173 Bausch & Lomb Americas Inc. $8.12 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364175 Bausch & Lomb Americas Inc. $7.31 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364177 Bausch & Lomb Americas Inc. $7.31 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140364179 Bausch & Lomb Americas Inc. $13.41 12/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147408633 Oyster Point Pharma, Inc. $17.42 07/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151405557 Dompe US, Inc. $32.38 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151975274 Glaukos Corporation $180.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151979622 Glaukos Corporation $191.59 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152158509 SUN PHARMACEUTICAL INDUSTRIES INC. $21.94 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.